NCT02543424 Motor and Cognitive Functions in Acquired and Developmental Brain Damaged Patients
| NCT ID | NCT02543424 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cliniques universitaires Saint-Luc- Université Catholique de Louvain |
| Condition | Cerebral Palsy |
| Study Type | INTERVENTIONAL |
| Enrollment | 400 participants |
| Start Date | 2015-04 |
| Primary Completion | 2028-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 400 participants in total. It began in 2015-04 with a primary completion date of 2028-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Neurological pathologies cause important and permanent disabilities in every day life. These pathologies can follow stoke, affecting two people per one thousand each year or cerebral palsy, affecting two births per one thousand each year. To date, the diagnosis and the rehabilitation of motor and cognitive problems has been carried out separately by different domains. For example, physiotherapists have focused on motor problems and neuropsychologists have focused on cognitive functions. However, a number of studies have demonstrated a link between motor and cognitive abilities in adults and children. The present study has three main aims: (1) to better evaluate motor and cognitive problems in brain damaged patients (all ages), (2) to understand the link between motor and cognitive abilities in patients and healthy participants and, (3) to propose new types of therapies based on the link between motor and cognitive functions.
Eligibility Criteria
Inclusion Criteria: * Congenital cerebral palsy and acquired brain injury children and adult patients * Presenting upper limb paresis and/or hemineglect * Between the age of 3 to 90. * Able to understand and carry out simple verbal instruction Exclusion Criteria: * IQ \< 70 * Severe aphasia, attentional disorder or psychiatric disorders * Neurodegenerative disorders
Contact & Investigator
Marie Alsamour
✉ marie.alsamour@uclouvain.beThierry Lejeune
PRINCIPAL INVESTIGATOR
St. Luc Hospital
Frequently Asked Questions
Who can join the NCT02543424 clinical trial?
This trial is open to participants of all sexes, aged 5 Years or older, studying Cerebral Palsy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02543424 currently recruiting?
Yes, NCT02543424 is actively recruiting participants. Contact the research team at marie.alsamour@uclouvain.be for enrollment information.
Where is the NCT02543424 trial being conducted?
This trial is being conducted at Ottignies, Belgium, Woluwé-Saint-Lambert, Belgium.
Who is sponsoring the NCT02543424 clinical trial?
NCT02543424 is sponsored by Cliniques universitaires Saint-Luc- Université Catholique de Louvain. The principal investigator is Thierry Lejeune at St. Luc Hospital. The trial plans to enroll 400 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.